Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 1: Metals

Toxicology Letters

Volumn 231, Issue 2, 2014, Pages 249-260

  Smolders, Roel ^a   Koch, Holger M ^b   Moos, Rebecca K ^b   Cocker, John ^c   Jones, Kate ^c   Warren, Nick ^c   Levy, Len ^d   Bevan, Ruth ^d   Hays, Sean M ^e   Aylward, Lesa L ^e  

^a FLEMISH INSTITUTE FOR TECHNOLOGICAL RESEARCH VITO   (Belgium)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c HEALTH AND SAFETY LABORATORY   (United Kingdom)

^d CRANFIELD UNIVERSITY   (United Kingdom)

^e LLP   (United States)

Author keywords

Biomonitoring; Inter and intra individual variability; Metals

Indexed keywords

ARSENIC; BIOLOGICAL MARKER; CADMIUM; CREATININE; MANGANESE; NICKEL; METAL; POLLUTANT;

ADULT; AGE; ARTICLE; BIOLOGICAL MONITORING; CREATININE URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MICTURITION; MIDDLE AGED; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; URINALYSIS; URINARY EXCRETION; URINE FLOW RATE; CHEMISTRY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; POLLUTANT; URINE;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; HUMANS; METALS;

EID: 84921328812     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.08.014     Document Type: Article

References (46)

1. Akerstrom M., Lundh T., Barregard L., Sallsten G. Sampling of urinary cadmium: differences between 24-h urine and overnight spot urine sampling, and impact of adjustment for dilution. Int. Arch. Occup. Environ. Health 2012, 85:189-196.
2. Anderson R.A., Colton T., Doull J., Marks J.G., Smith R.G., Bruce G.M., Finley B.L., Paustenbach D.J. Designing a biological monitoring program to assess community exposure to chromium - conclusions of an expert panel. J. Toxicol. Environ. Health 1993, 40:555-583.
3. Arisawa K., Nakano A., Honda S., Saito H. Reproducibility of urinary beta(2)-microglobulin and cadmium excretion among residents in a cadmium-polluted area during a 3-year period. Toxicol. Lett. 1997, 91:147-152.
4. Aylward L.L., Hays S.M., Smolders R., Koch H., Cocker J., Jones K., Warren N., Levy L., Bevan R. Sources of variability in biomarker concentrations. J. Toxicol. Environ. Health Part B 2014, 17:45-61.
5. Aylward L.L., Kirman C.R., Adgate J.L., McKenzie L.M., Hays S.M. Interpreting variability in population biomonitoring data: role of elimination kinetics. J. Expo. Sci. Environ. Epidemiol. 2012, 1-11.
6. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U. S. population: Implications for urinary biological monitoring measurements. Environ. Health Persp. 2005, 113:120-192.
7. Bevan R., Angerer J., Cocker J., Jones K., Koch H.M., Sepai O., Schoeters G., Smolders R., Levy L. Framework for the development and application of environmental biological monitoring guidance values. Regul. Toxicol. Pharmacol. 2012, 63:453-460.
8. Calafat A.M. The U. S. National Health and Nutrition Examination Survey and human exposure to environmental chemicals. Int. J. Hyg. Environ. Health 2012, 215:99-101.
9. Chaumont A., voisin C., Deumer G., Haufroid V., Annesi-Maesano I., Roels H., Thijs L., Staessen J., Bernard A. Associations of urinary cadmium with age and urinary proteins: further evidence of physiological variations unrelated to metal accumulation and toxicity. Environ. Health Persp. 2013, 121:1047-1053.
10. Cocker J., Mason H.J., Warren N.D., Cotton R.J. Creatinine adjustment of biological monitoring results. Occup. Med. 2011, 61:349-353.
11. Cone E.J., Caplan Y.H., Moser F., Robert T., Shelby M.K., Black D.L. Normalization of urinary drug concentrations with specific gravity and creatinine. J. Anal. Toxicol. 2009, 33:1-7.
12. DHHS Mandatory guidelines and proposed revisions to mandatory guidelines for federal workplace drug testing programs; Notices. Fed. Reg. 2004, 69:19644-19673.
13. Esteban M., Castaño A. Non-invasive matrices in human biomonitoring: a review. Environ. Int. 2009, 35:438-449.
14. EWDTS, 2002. European laboratory guidelines for legally defensible workplace drug testing. 1. Urine drug testing. Version 1.0. 39p.
15. Fréry N., Saoudi A., Garnier R., Zeghnoun A., Falq G. Exposition de la population franéaise aux substances chimiques de l'environnement 2011, 151. Institut de veille sanitaire, Saint-Maurice.
16. Fréry N., Vandentorren S., Etchevers A., Fillol C. Highlights of recent studies and future plans for the French human Biomonitoring (HBM) programme. Int. J. Hyg. Environ. Health 2012, 215:127-132.
17. Gaines L.G.T., Fent K.W., Flack S.L., Thomasen J.M., Ball L.M., Zhou H., Whittaker S.G., Nylander-French L.A.N. Effect of creatinine and specific gravity normalization on urinary biomarker 1,6-hexamethylene diamine. J. Environ. Monit. 2010, 12:591-599.
18. Gunier R.B., Horn-Ross P.L., Canchola A.J., Duffy C.N., Reynolds P., Hertz A., Barcia E., Rull R.P. Determinants and within-person variability of urinary cadmium concentrations among women in Northern California. Environ. Health Persp. 2013, 121:643-649.
19. Hoet P., Jacquerye C., Deumer G., Lison D., Haufroid V. Reference values and upper reference limits for 26 trace elements in the urine of adults living in Belgium. Clin. Chem. Lab. Med. 2013, 51:839-849.
20. Ikeda M., Ezaki T., Tsukahara T., Moriguchi J., Fukui Y., Okamoto S., Ukai H., Sakurai H. Bias induced by the use of creatinine-corrected values in evaluation of beta(2)-microgloblin levels. Toxicol. Lett. 2003, 145:197-207.
21. Jaffe M. Ueber den niederschlag welchen pikrinsaure in normalen harn erzeugt und uber eine neue reaction des kreatinins. Z. Physiol. Chem. 1886, 10:391-400. [in German].
22. Joas R., Casteleyn L., Biot P., Kolossa-Gehring M., Castano A., Angerer J., Schoeters G., Sepai O., Knudsen L.E., Joas A., Horvat M., Bloemen L. Harmonised human biomonitoring in Europe: activities towards an EU HBM framework. Int. J. Hyg. Environ. Health 2012, 215:172-175.
23. Karmaus W., Dimitrov P., Simeonov V., Tsolova S., Bonev A., Georgieva R. Metals and kidney markers in adult offspring of endemic nephropathy patients and controls: a two-year follow-up study. Environ. Health 2008, 7:11.
24. Koch H.M., Aylward L.L., Hays S.M., Smolders R., Moos R.K., Cocker J., Jones K., Warren N., Levy L., Bevan R. Inter- and intra-individual variation in urinary biomarker concentrations over a 6-day sampling period. Part 2: personal care product ingredients. Toxicol. Lett. 2014, (in this issue).
25. Koch H.M., Kolossa-Gehring M., Schröter-Kermani C., Angerer J., Brüning T. Bisphenol A in 24h urine and plasma samples of the German Environmental Specimen Bank from 1995 to 2009: a retrospective exposure evaluation. J. Expo. Sci. Environ. Epidemiol. 2012, 22:610-616.
26. Kolossa-Gehring M., Becker K., Conrad A., Schröter-Kermani C., Schulz C., Seiwert M. Environmental surveys, specimen bank and health related environmental monitoring in Germany. Int. J. Hyg. Environ. Health 2012, 215:120-126.
27. Manno M., Viau C., Cocker J., Colosio C., Lowry L., Mutti A., Nordberg M., Wang S. Biomonitoring for occupational health risk assessment (BOHRA). Toxicol. Lett. 2010, 192:3-16.
28. Meeker J.D., Barr D.B., Ryan L., Herrick R.F., Bennett D.H., Bravo R., Hauser R. Temporal variability of urinary levels of nonpersistent insecticides in adult men. J. Expo. Anal. Environ. Epidemiol. 2005, 15:271-281.
29. Miller R.C., Brindle E., Holman D.J., Shofer J., Klein N.A., Soules M.R., O'Connor K.A. Comparison of specific gravity and creatinine for normalizing urinary reproductive hormone concentrations. Clin. Chem. 2004, 50:924-932.
30. Muscat J.E., Liu A., Richie J.P. A comparison of creatinine vs. specific gravity to correct for urinary dilution of cotinine. Biomarkers 2011, 13:206-2011.
31. Navas-Acien A., Umans J., Howerd B.V., Goessler W., Francesconi K., Crainiceanu C., Silbergeld E., Guallar E. Urine arsenic concentrations and species excretion patterns in American Indian communities over a 10-year period: the strong heart study. Environ. Health Persp. 2009, 117:1428-1433.
32. Pearson M.A., Lu C., Schmotzer B.J., Waller L.A., Riederer A.M. Evaluation of physiological measures for correcting variation in urinary output: implications for assessing environmental chemical exposure in children. J. Expo. Sci. Environ. Epidemiol. 2009, 19:336-342.
33. Pirkle J.L., Needham L.L., Sexton K. Improving exposure assessment by monitoring human tissues for toxic chemicals. J. Expo. Anal. Environ. Epidemiol. 1995, 5:405-424.
34. Polkowska Z., Kozlowska K., Namiesnik J., Przyjazny A. Biological fluids as a source of information on the exposure of man to environmental chemical agents. Crit. Rev. Anal. Chem. 2004, 35:105-119.
35. Preau J.L., Wong L.Y., Silva M.J., Needham L.L., Calafat A.M. Variability over 1 week in the urinary concentrations of metabolites of diethyl phthalate and di(2-ethylhexyl) phthalate among eight adults: an observational study. Environ. Health Persp. 2010, 118:1748-1754.
36. Rigas M.L., Okino M.S., Quackenboss J.J. Use of a pharmacokinetic model to assess chlorpyrifos exposure and dose in children, based on urinary biomarker measurements. Toxicol. Sci. 2001, 61:374-381.
37. Schütze A., Kolossa-Gehring M., Apel P., Brüning T., Koch H.M. Entering markets and bodies: increasing levels of the novel plasticizer DINCH® in 24h urine samples from the German Environmental Specimen Bank. Int. J. Hyg. Environ. Health 2014, 217:421-426.
38. Smolders R., Koppen G., Schoeters G. Translating biomonitoring data into risk management and policy implementation options for a European network on human biomonitoring. Environ. Health 2008, 7:S2.
39. Smolders R., Schramm K.-W., Nickmilder M., Schoeters G. Applicability of non-invasively collected matrices for human biomonitoring. Environ. Health 2009, 8:8.
40. Steunpunt Milieu and Gezondheid, 2011 Uitgebreid resultatenrapport: Resultaten Vlaams human biomonitorings programma - Luik referentiebiomonitoring (2007-2011). 202p.
41. Stokstad E. Biomonitoring: pollution gets personal. Science 2004, 304:1892-1894.
42. WHO Biological Monitoring of Chemical Exposure in the Workplace 1996, Vol. 1. World Health Organization, Geneva.
43. Wielgomas B. Variability of urinary excretion of pyrethroid metabolites in seven persons over seven consecutive days - implications for observational studies. Toxicol. Lett. 2013, 221:15-22.
44. Wiesmüller G.A., Eckard R., Dobler L., Günsel A., Oganowski M., Schröter-Kermani C., Schlüter C., Gies A., Kemper F.H. The Environmental Specimen Bank for human tissues as part of the German Environmental Specimen Bank. Int. J. Hyg. Environ. Health 2007, 210:299-305.
45. Wittassek M., Wiesmüller G.A., Koch H.M., Eckard R., Dobler L., Helm D., Müller J., Angerer J., Schlüter C. Internal phthalate exposure over the last two decades? A retrospective human biomonitoring study. Int. J. Hyg. Environ. Health 2007, 210:319-333.
46. Ye X.Y., Wong L.Y., Bishop A.M., Calafat A.M. Variability of urinary concentrations of bisphenol A in spot samples, first morning voids, and 24-h collections. Environ. Health Persp. 2011, 119:983-988.